H2-antagonists in the treatment of colon and breast cancer

ISSN： 1044-579X

Source： Seminars in Cancer Biology, Vol.10, Iss.1, 2000-02, pp. : 3-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Induction of LGR5 by H2O2 treatment is associated with cell proliferation via the JNK signaling pathway in colon cancer cells

International Journal of Oncology, Vol. 41, Iss. 5, 2012-01 ,pp. : 1744-1750

Spandidos Publications

Access to resources Recommend Favorite

Treatment strategy for HER2-positive breast cancer

By Mukai Hirofumi

International Journal of Clinical Oncology, Vol. 15, Iss. 4, 2010-08 ,pp. : 335-340

Springer Publishing Company

Access to resources Recommend Favorite

Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer

By Farrow D.C.

Cancer Causes and Control, Vol. 11, Iss. 3, 2000-03 ,pp. : 231-238

Springer Publishing Company

Access to resources Recommend Favorite

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment, Vol. 79, Iss. 2, 2003-05 ,pp. : 281-285

Springer Publishing Company

Access to resources Recommend Favorite

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment, Vol. 68, Iss. 2, 2001-07 ,pp. : 1-2

Springer Publishing Company

Access to resources Recommend Favorite